Seattle Genetics (SGEN) Updates on Select ADC Programs by Roche's (RHHBY) Genentech
Tweet Send to a Friend
Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted clinical data from two antibody-drug conjugate (ADC) programs in development by Genentech, a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
